Monday, May 23

Tag: Biobohemia Pushes Forward Antigenic Essence Technology in Released Paper

Biobohemia Pushes Forward Antigenic Essence Technology in Released Paper
Science

Biobohemia Pushes Forward Antigenic Essence Technology in Released Paper

CAMBRIDGE, MA / ACCESSWIRE / May 10, 2022 / Biobohemia's scientists share in a released paper ("Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen Compositions") the experience gained over the past year in advancing antigen essence technology, including that related to relationships with contract manufacturing organizations, the upgrading of existing experimental cancer vaccines, and the legal and ethical aspects of the technology.Biobohemia is a pioneer in work on antigenic essence, a new technology for the creation of cancer vaccines. Although this technology has been recognized as a promising platform for this purpose ("Cancer Vaccine Platforms", Report 2022), its novelty poses unique challenges. The released paper describes the experience gained by the...